224 related articles for article (PubMed ID: 27899520)
1. Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated With Different Outcomes Among Patients With Venous Thromboembolism?
Spyropoulos AC; Preblick R; Kwong WJ; Lingohr-Smith M; Lin J
Clin Appl Thromb Hemost; 2017 Sep; 23(6):532-541. PubMed ID: 27899520
[TBL] [Abstract][Full Text] [Related]
2. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
Lin J; Lingohr-Smith M; Kwong WJ
J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
[TBL] [Abstract][Full Text] [Related]
3. Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States.
Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
J Manag Care Spec Pharm; 2015 Oct; 21(10):965-72. PubMed ID: 26402395
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.
Bullano MF; Willey V; Hauch O; Wygant G; Spyropoulos AC; Hoffman L
J Manag Care Pharm; 2005 Oct; 11(8):663-73. PubMed ID: 16194130
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes and adherence to guideline recommendations during the initial treatment of acute venous thromboembolism.
Martinez K; Kosirog E; Billups SJ; Clark NP; Delate T; Witt DM
Ann Pharmacother; 2015 Aug; 49(8):869-75. PubMed ID: 25931575
[TBL] [Abstract][Full Text] [Related]
6. Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement.
Selby R; Borah BJ; McDonald HP; Henk HJ; Crowther M; Wells PS
Thromb Res; 2012 Aug; 130(2):166-72. PubMed ID: 22365491
[TBL] [Abstract][Full Text] [Related]
7. Clinical and economic outcomes with appropriate or partial prophylaxis.
Amin AN; Lin J; Johnson BH; Schulman KL
Thromb Res; 2010 Jun; 125(6):513-7. PubMed ID: 19931121
[TBL] [Abstract][Full Text] [Related]
8. The economic implications of switching to rivaroxaban from enoxaparin plus vitamin K antagonist in the treatment of venous thromboembolism.
Patel AA; Ogden K; Mody SH; Bookhart B
J Med Econ; 2015 May; 18(5):323-32. PubMed ID: 25557176
[TBL] [Abstract][Full Text] [Related]
9. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S
J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169
[TBL] [Abstract][Full Text] [Related]
10. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
Bergmann JF; Cohen AT; Tapson VF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Anderson FA;
Thromb Haemost; 2010 Apr; 103(4):736-48. PubMed ID: 20135072
[TBL] [Abstract][Full Text] [Related]
12. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632
[TBL] [Abstract][Full Text] [Related]
13. Inpatient thromboprophylaxis use in U.S. hospitals: adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients.
Amin AN; Stemkowski S; Lin J; Yang G
J Hosp Med; 2009 Oct; 4(8):E15-21. PubMed ID: 19827045
[TBL] [Abstract][Full Text] [Related]
14. Role of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism.
Dobesh PP; Trujillo TC; Finks SW
Pharmacotherapy; 2013 Jun; 33(6):650-64. PubMed ID: 23553464
[TBL] [Abstract][Full Text] [Related]
15. Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens.
Trujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M;
Thromb Haemost; 2017 Jan; 117(2):382-389. PubMed ID: 27786333
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and treatment patterns of patients with venous thromboembolism (VTE) transitioning from hospital to post-discharge settings.
Burton T; Hlavacek P; Guo JD; Rosenblatt L; Mardekian J; Ferri M; Russ C; Kline JA
Hosp Pract (1995); 2020 Oct; 48(4):196-205. PubMed ID: 32720816
[TBL] [Abstract][Full Text] [Related]
17. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
18. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.
Amin AN; Lin J; Lenhart G; Schulman KL
Thromb Haemost; 2009 Aug; 102(2):321-6. PubMed ID: 19652883
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
20. Treatment of venous thromboembolism.
Wells PS; Forgie MA; Rodger MA
JAMA; 2014 Feb; 311(7):717-28. PubMed ID: 24549552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]